HKD 0.02
(-5.26%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -38.74 Million HKD | 56.39% |
2022 | -88.85 Million CNY | 15.29% |
2021 | -104.89 Million CNY | -209.33% |
2020 | -33.9 Million CNY | 29.94% |
2019 | -48.39 Million CNY | 88.78% |
2018 | -431.43 Million CNY | -152.68% |
2017 | -170.74 Million CNY | -53.56% |
2016 | -111.18 Million CNY | -121.01% |
2015 | -50.3 Million CNY | -125.11% |
2014 | 200.39 Million CNY | 0.41% |
2013 | 199.57 Million CNY | -17.23% |
2012 | 241.11 Million CNY | 31.08% |
2011 | 183.94 Million CNY | 27.32% |
2010 | 144.46 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -29.51 Million HKD | 0.0% |
2023 FY | -38.74 Million HKD | 56.39% |
2023 Q4 | -18.33 Million HKD | 0.0% |
2023 Q2 | -21.47 Million HKD | 0.0% |
2022 Q2 | -63.07 Million HKD | 0.0% |
2022 FY | -88.85 Million CNY | 15.29% |
2021 FY | -104.89 Million CNY | -209.33% |
2020 FY | -33.9 Million CNY | 29.94% |
2019 FY | -48.39 Million CNY | 88.78% |
2018 FY | -431.43 Million CNY | -152.68% |
2017 FY | -170.74 Million CNY | -53.56% |
2016 FY | -111.18 Million CNY | -121.01% |
2015 FY | -50.3 Million CNY | -125.11% |
2014 FY | 200.39 Million CNY | 0.41% |
2013 FY | 199.57 Million CNY | -17.23% |
2013 Q4 | 50.09 Million CNY | 0.41% |
2013 Q3 | 49.89 Million CNY | 0.0% |
2013 Q2 | 49.89 Million CNY | 0.0% |
2013 Q1 | 49.89 Million CNY | 0.0% |
2012 Q4 | 49.89 Million CNY | -17.23% |
2012 Q1 | 60.27 Million CNY | 0.0% |
2012 FY | 241.11 Million CNY | 31.08% |
2012 Q2 | 60.27 Million CNY | 0.0% |
2012 Q3 | 60.27 Million CNY | 0.0% |
2011 Q2 | 45.98 Million CNY | 0.0% |
2011 FY | 183.94 Million CNY | 27.32% |
2011 Q4 | 60.27 Million CNY | 31.08% |
2011 Q3 | 45.98 Million CNY | 0.0% |
2011 Q1 | 45.98 Million CNY | 0.0% |
2010 FY | 144.46 Million CNY | 0.0% |
2010 Q4 | 45.98 Million CNY | 27.32% |
2010 Q3 | 36.11 Million CNY | 0.0% |
2010 Q2 | 36.11 Million CNY | 0.0% |
2010 Q1 | 36.11 Million CNY | 0.0% |
2009 Q4 | 36.11 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | -15.11 Million HKD | -156.422% |
Innovative Pharmaceutical Biotech Limited | 103.4 Million HKD | 137.473% |
China Overseas Nuoxin International Holdings Limited | -15.5 Million HKD | -149.874% |
Huasheng International Holding Limited | -31.44 Million HKD | -23.24% |
Fourace Industries Group Holdings Limited | 38.71 Million HKD | 200.083% |
Evergreen Products Group Limited | 51.01 Million HKD | 175.96% |
EC Healthcare | -18.94 Million HKD | -104.507% |
Ming Fai International Holdings Limited | 104.18 Million HKD | 137.193% |
Blue Moon Group Holdings Limited | 325.3 Million HKD | 111.911% |
SuperRobotics Holdings Limited | -27.75 Million HKD | -39.602% |
Takbo Group Holdings Limited | 14.65 Million HKD | 364.347% |
Hyfusin Group Holdings Limited | 102.28 Million HKD | 137.882% |